Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Invested Capital: 2017-2025

Historic Invested Capital for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $149.0 million.

  • Puma Biotechnology's Invested Capital rose 27.97% to $149.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.0 million, marking a year-over-year increase of 27.97%. This contributed to the annual value of $137.5 million for FY2024, which is 57.20% up from last year.
  • As of Q3 2025, Puma Biotechnology's Invested Capital stood at $149.0 million, which was up 7.40% from $138.7 million recorded in Q2 2025.
  • Puma Biotechnology's 5-year Invested Capital high stood at $149.0 million for Q3 2025, and its period low was -$10.9 million during Q3 2021.
  • Over the past 3 years, Puma Biotechnology's median Invested Capital value was $96.3 million (recorded in 2024), while the average stood at $99.1 million.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 307.60% in 2021, then surged by 983.40% in 2022.
  • Over the past 5 years, Puma Biotechnology's Invested Capital (Quarterly) stood at -$2.4 million in 2021, then spiked by 983.40% to $21.6 million in 2022, then spiked by 304.66% to $87.4 million in 2023, then soared by 57.20% to $137.5 million in 2024, then grew by 27.97% to $149.0 million in 2025.
  • Its last three reported values are $149.0 million in Q3 2025, $138.7 million for Q2 2025, and $142.4 million during Q1 2025.